Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism

Abstract Background and Objective Esmethadone (dextromethadone; d-methadone; S-methadone (+)-methadone; REL-1017) is the opioid inactive dextro-isomer of racemic methadone. Esmethadone is a low potency N-methyl-D-aspartate (NMDA) receptor channel blocker with higher affinity for GluN2D subtypes. Esm...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nicola Ferri, Sara De Martin, James Stuart, Sergio Traversa, Franco Folli, Marco Pappagallo, Cedric O’Gorman, Clotilde Guidetti, Andrea Mattarei, Charles E. Inturrisi, Paolo L. Manfredi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2023-11-01
coleção:	Drugs in R&D
Acesso em linha:	https://doi.org/10.1007/s40268-023-00450-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!